|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07C 229/60 | (2006.01) |
| (11) | Number of the document | 1446379 |
| (13) | Kind of document | T |
| (96) | European patent application number | 02780622.3 |
| Date of filing the European patent application | 2002-11-12 | |
| (97) | Date of publication of the European application | 2004-08-18 |
| (45) | Date of publication and mention of the grant of the patent | 2009-04-29 |
| (46) | Date of publication of the claims translation | 2009-07-27 |
| (86) | Number | PCT/US2002/036237 |
| Date | 2002-11-12 |
| (87) | Number | WO 2003/042164 |
| Date | 2003-05-22 |
| (30) | Number | Date | Country code |
| 338194 P | 2001-11-13 | US | |
| 343771 P | 2001-12-28 | US |
| (72) |
MORAN, Edmund, J., US
JACOBSEN, John, R., US
LEADBETTER, Michael, R., US
NODWELL, Matthew, B., CA
TRAPP, Sean, G., US
AGGEN, James, US
CHURCH, Timothy, J., US
|
| (73) |
Theravance, Inc.,
901 Gateway Boulevard, South San Francisco, CA 94080,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Arilanilino beta-2 adrenerginio receptoriaus agonistai |
| ARYL ANILINE BETA-2 ADRENERGIC RECEPTOR AGONISTS |
| Payment date | Validity (years) | Amount | |
| 2009-10-20 | 8 | 640.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2010-11-12 |